과제정보
This study was supported by National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. NRF-2019R1C1C1006851 and -2019R1F1A1042044).
참고문헌
- Khashab MA, Yong E, Lennon AM, et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc 2011;73:691-696. https://doi.org/10.1016/j.gie.2010.08.030
- Oberg K. Pancreatic endocrine tumors. Semin Oncol 2010;37:594-618. https://doi.org/10.1053/j.seminoncol.2010.10.014
- Kloppel G, Rindi G, Perren A, Komminoth P, Klimstra DS. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 2010;456:595-597. https://doi.org/10.1007/s00428-010-0924-6
- Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424. https://doi.org/10.1159/000085237
- Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007;451:757-762. https://doi.org/10.1007/s00428-007-0452-1
- Han X, Xu X, Ma H, et al. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology. Endocr Connect 2018;7:355-363. https://doi.org/10.1530/EC-17-0388
- Bettini R, Partelli S, Boninsegna L, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 2011;150:75-82. https://doi.org/10.1016/j.surg.2011.02.022
- Falconi M, Bartsch DK, Eriksson B, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 2012;95:120-134. https://doi.org/10.1159/000335587
- Paik WH, Lee HS, Lee KJ, et al. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: a multicenter nationwide study. Pancreatology 2021;21:208-214. https://doi.org/10.1016/j.pan.2020.11.016
- Kurita Y, Hara K, Kuwahara T, et al. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis. J Gastroenterol 2020;55:543-552. https://doi.org/10.1007/s00535-019-01655-w
- Jung JG, Lee KT, Woo YS, et al. Behavior of small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs). Medicine (Baltimore) 2015;94:e983. https://doi.org/10.1097/md.0000000000000983
- Kishi Y, Shimada K, Nara S, Esaki M, Hiraoka N, Kosuge T. Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size. Ann Surg Oncol 2014;21:2882-2888. https://doi.org/10.1245/s10434-014-3701-y
- Yang G, Ji M, Chen J, et al. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET). Int J Oncol 2017;50:567-574. https://doi.org/10.3892/ijo.2016.3826
- Lee KJ, Cho JH, Lee SH, et al. Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea. Cancer Chemother Pharmacol 2017;80:799-805. https://doi.org/10.1007/s00280-017-3421-7
- Martin-Perez E, Capdevila J, Castellano D, et al. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE). Neuroendocrinology 2013;98:156-168. https://doi.org/10.1159/000355152
- Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS Consensus Guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology 2016;103:186-194. https://doi.org/10.1159/000443172
- Larghi A, Capurso G, Carnuccio A, et al. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 2012;76:570-577. https://doi.org/10.1016/j.gie.2012.04.477
- Hasegawa T, Yamao K, Hijioka S, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy 2014;46:32-38. https://doi.org/10.1055/s-0033-1344958
- Howe JR, Merchant NB, Conrad C, et al. The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas 2020;49:1-33. https://doi.org/10.1097/mpa.0000000000001454
- Boutsen L, Jouret-Mourin A, Borbath I, van Maanen A, Weynand B. Accuracy of pancreatic neuroendocrine tumour grading by endoscopic ultrasound-guided fine needle aspiration: analysis of a large cohort and perspectives for improvement. Neuroendocrinology 2018;106:158-166. https://doi.org/10.1159/000477213
- Mizumoto T, Toyama H, Terai S, et al. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics. Pancreatology 2017;17:956-961. https://doi.org/10.1016/j.pan.2017.08.003
- Takumi K, Fukukura Y, Higashi M, et al. Pancreatic neuroendocrine tumors: correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Eur J Radiol 2015;84:1436-1443. https://doi.org/10.1016/j.ejrad.2015.05.005
- Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: spectrum of imaging findings and pathological grading. Eur J Radiol 2015;84:2103-2109. https://doi.org/10.1016/j.ejrad.2015.08.014
- Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol 2017;24:1127-1133. https://doi.org/10.1245/s10434-016-5663-8
- Mintziras I, Keck T, Werner J, et al. Implementation of current ENETS guidelines for surgery of small (≤2 cm) pancreatic neuroendocrine neoplasms in the German surgical community: an analysis of the prospective DGAV StuDoQ|Pancreas registry. World J Surg 2019;43:175-182. https://doi.org/10.1007/s00268-018-4751-2
- Massironi S, Rossi RE, Zilli A, Casazza G, Ciafardini C, Conte D. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival. Oncotarget 2016;7:18978-18983. https://doi.org/10.18632/oncotarget.7902
- Sallinen V, Le Large TY, Galeev S, et al. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis. HPB (Oxford) 2017;19:310-320. https://doi.org/10.1016/j.hpb.2016.12.010
- Sharpe SM, In H, Winchester DJ, Talamonti MS, Baker MS. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg 2015;19:117-123;discussion 123. https://doi.org/10.1007/s11605-014-2615-0
- Finkelstein P, Sharma R, Picado O, et al. Pancreatic neuroendocrine tumors (panNETs): analysis of overall survival of nonsurgical management versus surgical resection. J Gastrointest Surg 2017;21:855-866. https://doi.org/10.1007/s11605-017-3365-6
- Turaga KK, Kvols LK. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 2011;61:113-132. https://doi.org/10.3322/caac.20097
- de Herder WW, Niederle B, Scoazec JY, et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006;84:183-188. https://doi.org/10.1159/000098010
- Paik WH, Seo DW, Dhir V, Wang HP. Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic neoplasm. Medicine (Baltimore) 2016;95:e2538. https://doi.org/10.1097/md.0000000000002538
- Rimbas M, Horumba M, Rizzatti G, et al. Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms. Dig Endosc 2020;32:1031-1041. https://doi.org/10.1111/den.13635
- Imperatore N, de Nucci G, Mandelli ED, et al. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature. Endosc Int Open 2020;8:E1759-E1764. https://doi.org/10.1055/a-1261-9605